Bulimia Nervosa is characterised by alternating episodes of uncontrolled binge eating, followed by compensatory behaviors aimed at preventing weight gain in order to maintain a ‘slim’ appearance.
Current studies indicate a lifetime prevalence of 1-3% in German-speaking countries. The disorder often begins in adolescence and has a mortality rate of 1.1-5.8% over the lifetime of those affected.
Individuals with Bulimia Nervosa often experience a range of emotional and physical consequences. Many develop depressive moods along with anxiety disorders, while a significant proportion have histories of alcohol or substance use. Physiologically, frequent vomiting can cause severe damage to tooth enamel (generating tooth decay), while even the mechanical act of inducing vomiting may lead to scars or calluses on the hands. Additionally, salivary glands, particularly the parotid gland, may become noticeably enlarged. The cycle of binge eating plus purging disrupts fluid along with electrolyte balance, potentially resulting in kidney damage, edema, and cardiac arrhythmias. Lastly, chronic complications include gastric distension, inflammation of the stomach plus esophagus, along with vitamin and other nutrient deficiencies. These issues are compounded by the constant strain on the digestive system, leading to long-term health risks.
Therapy for bulimia primarily focuses on: